AHA 2023 Insights

 

 
 

 

AHA 2023 Insights: Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity and Cardiovascular Disease Who Do Not Have Diabetes - The SELECT Trial

1,445 views
November 20, 2023
Comments 2
Login to view comments. Click here to Login